Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chavez

Showing results (61-70 of 285) with videos related to

Pageof 29
Sort By:
Neuroscience|August 15, 2006
Acute hypoxia and programmed cell death in developing CNS: Differential vulnerability of chick optic tectum layersV M Pozo Devoto, J C Chavez, S Fiszer de Plazas
Poultry Science|March 24, 2006
Nitrogen emissions from broilers measured by mass balance over eighteen consecutive flocksC D Coufal, C Chavez, P R Niemeyer, et al.
The Journal of Biological Chemistry|August 30, 2000
The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxiaF H Agani, P Pichiule, J C Chavez, et al.
International Journal of Hematologic Oncology|September 20, 2021
Anti-CD19 chimeric antigen receptor T-cell therapy in B-cell lymphomas: current status and future directionsJulio C Chavez, Farah Yassine, Jose Sandoval-Sus, et al.
Mini Reviews in Medicinal Chemistry|June 22, 2006
Adiponectin, structure, function and pathophysiological implications in non-alcoholic fatty liver diseaseN Méndez-Sánchez, N C Chavez-Tapia, D Zamora-Valdés, et al.
Vaccine|December 1, 1991
In vivo protection against scorpion toxins by liposomal immunizationC Chavez-Olortegui, D A Amara, H Rochat, et al.
Therapeutics and Clinical Risk Management|June 19, 2018
Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin's lymphomaMichael D Jain, Christina A Bachmeier, Vania H Phuoc, et al.
Expert Review of Anticancer Therapy|January 20, 2023
Lisocabtagene maraleucel for relapsed or refractory large B-cell non-Hodgkin lymphomaRazan Mohty, Yenny Moreno Vanegas, Julio C Chavez, et al.
Advances in Experimental Medicine and Biology|October 18, 2003
HIF-1 alpha and VEGF expression after transient global cerebral ischemiaPaolo Pichiule, Faton Agani, Juan C Chavez, et al.
Current Research in Translational Medicine|August 20, 2020
Real world experience of approved chimeric antigen receptor T-cell therapies outside of clinical trialsFarah Yassine, Madiha Iqbal, Hemant Murthy, et al.
Pageof 29

Showing results (61-70 of 285) with videos related to

Sort By:
Pageof 29
Neuroscience|August 15, 2006
Acute hypoxia and programmed cell death in developing CNS: Differential vulnerability of chick optic tectum layersV M Pozo Devoto, J C Chavez, S Fiszer de Plazas
Poultry Science|March 24, 2006
Nitrogen emissions from broilers measured by mass balance over eighteen consecutive flocksC D Coufal, C Chavez, P R Niemeyer, et al.
The Journal of Biological Chemistry|August 30, 2000
The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxiaF H Agani, P Pichiule, J C Chavez, et al.
International Journal of Hematologic Oncology|September 20, 2021
Anti-CD19 chimeric antigen receptor T-cell therapy in B-cell lymphomas: current status and future directionsJulio C Chavez, Farah Yassine, Jose Sandoval-Sus, et al.
Mini Reviews in Medicinal Chemistry|June 22, 2006
Adiponectin, structure, function and pathophysiological implications in non-alcoholic fatty liver diseaseN Méndez-Sánchez, N C Chavez-Tapia, D Zamora-Valdés, et al.
Vaccine|December 1, 1991
In vivo protection against scorpion toxins by liposomal immunizationC Chavez-Olortegui, D A Amara, H Rochat, et al.
Therapeutics and Clinical Risk Management|June 19, 2018
Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin's lymphomaMichael D Jain, Christina A Bachmeier, Vania H Phuoc, et al.
Expert Review of Anticancer Therapy|January 20, 2023
Lisocabtagene maraleucel for relapsed or refractory large B-cell non-Hodgkin lymphomaRazan Mohty, Yenny Moreno Vanegas, Julio C Chavez, et al.
Advances in Experimental Medicine and Biology|October 18, 2003
HIF-1 alpha and VEGF expression after transient global cerebral ischemiaPaolo Pichiule, Faton Agani, Juan C Chavez, et al.
Current Research in Translational Medicine|August 20, 2020
Real world experience of approved chimeric antigen receptor T-cell therapies outside of clinical trialsFarah Yassine, Madiha Iqbal, Hemant Murthy, et al.
Pageof 29